Centre to extend all help to make Tripura ‘aatmanirbhar' in animal husbandry, fisheries sectors: Union Minister
Union Fisheries, Animal Husbandry and Dairying Minister Rajiv Ranjan Singh Saturday said the Centre would extend all required assistance to make Tripura atmanirbhar (self-dependent) in milk and fish production.
Speaking at the inauguration of a milk processing plant at Bamutia in West Tripura district, Singh said milk production is increasing by 6 per cent in India every year against the world average of a 2 per cent hike.
'Tripura has huge scope in the animal husbandry and fisheries sector,' the minister further said.
Sharing a success story of the National Dairy Development Board (NDDB), the Union minister stated that the capacity of milk collection at an old milk collection centre in Varanasi increased to 3 lakh litres per day from 11,000 litres per day after it was taken over by NDDB.
He, thereafter, asked the Tripura government to take strong initiatives to eradicate foot and mouth disease among cattle, stating that any outbreak of the disease makes it difficult to export dairy products to European countries.
The newly launched milk processing unit in Tripura can handle 40,000 litres of milk every day, of which 10,000 litres would be turned into curd and buttermilk.
Tripura set a 10-year target for food self-sufficiency in 2002-03.
The target was not achieved at the time of evaluation in 2012-13, with barely 25,000 MT of meat, 12.5 crore eggs and 1.05 MT of milk produced annually. Later, the erstwhile Left Front government set a new target for self-sufficiency in food production by 2020. But despite repeated attempts, it failed to cut down on its import dependency.
In 2020, then chief minister Biplab Kumar Deb said his government was trying to double the income of farmers, including those in the dairy and poultry sectors.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Mint
21 minutes ago
- Mint
Centre to introduce minimum import price on pharmaceutical raw materials to curb cheap Chinese imports
New Delhi: India plans to introduce a minimum import price (MIP) for select pharmaceutical raw materials in a move to shield its domestic industry from a flood of cheap Chinese imports, two people directly involved in the process said, a step that will also shore up India's status as the world's largest supplier of generic drugs. India accounts for about 20% of the global supply of generic drugs and manufactures about 60,000 generic brands, across 60 categories. The plan comes against the backdrop of the Centre's move to bulk up its Production Linked incentive (PLI) scheme for generic drugs by including more molecules used in manufacturing key starting materials (KSMs), drug intermediates, and Active Pharmaceutical Ingredients (APIs). KSMs and intermediates are chemical compounds used to synthesize APIs, which are the main components of a drug. 'The government is working on a plan to impose a minimum import price on all PLI based pharmaceutical products. The plan is to protect the domestic industry so that they are able to continue to do the business and to make India self-reliant," said one of the two people mentioned above. The measure seeks to build on India's recent success with domestic production of critical antibiotics such as Penicillin G. The API industry is a crucial segment of the pharmaceutical sector, accounting for about 35% of the market. However, India is dependent on imports for 80% of its bulk drug requirement. Bolstering self reliance The move also aims to bolster India's goal of self-reliance in the pharmaceutical sector. The heavy reliance on China, the world's largest producer and exporter of APIs, creates significant risks for India's medicine supply chain. In 2021, the government launched the ₹15,000 crore PLI scheme for the pharmaceuticals sector. There are about 500 API manufacturers in India, which account for about 8% of the global API industry. In addition, the production of APIs for essential medicines is also promoted through a dedicated PLI scheme for bulk drugs, KSMs and APIs. The government is seeking new applications as the previous iteration of the PLI scheme failed to meet the expectations due to dumping of cheap commodities from China. Also read | India curbs exports of 13 key pharma ingredients These schemes are aimed at protecting and encouraging domestic ingredient manufacturing which is seen as a critical step in securing the future growth and stability of India's pharma sector. According to the second person, the plan is a direct response to appeals from the domestic API industry, which has struggled to compete with the low prices of Chinese products. 'Actually, industry needs protection like some anti-dumping measures and MIP to make India self-reliant," the second person said, referring to a practice where a country 'dumps' its exports in other countries at prices that are less that what it costs to make these goods. Exports marginally higher As per commerce ministry data, India recorded a modest trade surplus in bulk drugs and intermediates in FY25, with exports totalling $4.90 billion and imports at $4.64 billion. In FY24, exports stood at $4.79 billion, slightly ahead of imports worth $4.56 billion, again resulting in a surplus. Similarly, in FY23, exports were $4.77 billion compared to imports of $4.51 billion, continuing the trend of a positive trade balance in this segment. The Indian Drugs Manufacturers' Association (IDMA) called for a cautious and data-driven approach to the proposal for imposing minimum import prices on select APIs and KSMs. The industry body has warned the government against a blanket application of the trade measure. 'We believe that a data-backed, well-studied and balanced approach should be considered," said Viranchi Shah, national spokesperson for IDMA. While the move is intended to discourage cheap imports and support the domestic pharma industry, Shah cautioned that India's strong position in finished formulation exports must not be compromised. Also read | India seeks financial details of pharmaceutical marketing practices 'The minimum import price should not come as a blanket strategy across the board, considering that India also has a very strong formulation industry," he said. 'Our industry has to remain competitive both domestically and globally." IDMA reiterated its support to the government's self-reliance push under the 'Atma-Nirbhar Bharat" campaign but urged policy planners to ensure that trade interventions like MIP do not end up hampering Indian exports by making them more costly. Queries sent to the spokespersons of India's commerce ministry, and department of pharmaceuticals on Friday and the Embassy of China in New Delhi on Saturday remained unanswered till the press time. China dependent Ajay Srivastava, co-founder of the Global Trade Research Initiative (GTRI), a policy think tank, said India's chemicals and pharmaceuticals sector—which plays a crucial role in healthcare, agriculture, and industry—is becoming heavily dependent on imports from China. 'This growing reliance not only exposes India to supply chain vulnerabilities but also raises significant strategic concerns, especially in the current global climate where geopolitical tensions and trade disruptions are increasingly common. Strengthening domestic production is thus not just an economic priority but a national security imperative," he said. A GTRI report from April 2024 states that India's imports of chemicals and pharmaceuticals reached $54.8 billion in FY2024. Between 2007 and 2022, China's share in these imports rose sharply from 18% to 29%, with imports from China increasing nearly fourfold—from $4.4 billion to $17.4 billion. Also read | Bitter pill for Indian pharma as Trump tariffs could hurt exports by $2.25 bn Although imports from other countries has also ballooned, the heavy dependence on China remains a major strategic concern. In 2022, India's chemical and pharmaceutical imports totaled $76.94 billion, with China accounting for 26.8%, followed by Saudi Arabia, the US, Japan, and Russia. There has been a notable increase in antibiotic imports from $551.2 million in 2007-10 to $1.27 billion in 2020-22, an increase of 130.7%. Here too, China's market share climbed to 81.7%, underscoring a high dependency on Chinese pharmaceutical products essential for addressing widespread public health needs in India, it said. Instrument of control A minimum import price is an instrument used by countries to control surplus imports. As a case in point, India has used MIPs to curb the import of steel and agricultural products like onions and pulses. By filtering out extremely low-cost imports, MIP also helps maintain quality standards, ensuring that only manufacturers capable of meeting cost-based compliance and quality norms supply APIs to the Indian market. 'While such a measure could lead to a short-term increase in input costs for drug makers dependent on Chinese supplies, it is seen as a necessary step for strengthening the domestic pharmaceutical ecosystem and reducing strategic vulnerabilities," said Abhash Kumar, a trade economist and assistant professor of economics at Delhi University. Also read | India eyes Asean to boost pharma exports An MIP is not outright banned under WTO rules, but it can face challenges if used unfairly or for extended periods. The WTO also allows rules-based instruments like tariffs or anti-dumping duties backed by formal investigations. India imposed an MIP on steel in 2016, but later replaced it with WTO-compliant remedies like safeguard duties.
Indian Express
25 minutes ago
- Indian Express
Israel says Hamas Gaza chief Mohammed Sinwar's body recovered
The Israeli military recovered the body of Gaza-based Hamas militant group's de facto chief Mohammed Sinwar in a tunnel beneath the European Hospital in the southern city of Khan Younis, the Israeli Defence Forces (IDF) announced on Sunday. The IDF made the announcement after it conducted a thorough identification of the body via DNA checks, though Hamas is yet to publicly confirm the death of Sinwar. Mohammed Sinwar, 49, was killed by the Israeli military in an air strike on May 13, in which at least 28 Palestinians were killed and dozens of them were injured, a Hamas-run civil defence agency had claimed. Mohammad Sinwar was responsible for the deaths of countless civilians. He was eliminated in an IDF & ISA strike on May 13. His body was found beneath the European hospital in Khan Yunis—more proof of how Sinwar, and Hamas, hide behind their civilians and purposely embed… — Israel Defense Forces (@IDF) June 8, 2025 Sinwar was the brother of Hamas leader Yahya Sinwar who was killed by the Israeli forces in southern Gaza in October last year. Sinwar was killed in a massive Israeli airstrike on the hospital in May, a day after Hamas released Israeli-American soldier Edan Alexander. Sinwar's body was recovered alongside Hamas's Rafah Brigade commander Mohammad Sabaneh's body in southern Gaza, the IDF informed. The military added that other bodies were also located which it was looking to identify. 🎥 Weapons, cash and ammunition: IDF Spokesperson BG Effie Defrin reveals what was found inside the tunnel beneath the European Hospital in Khan Yunis. More proof that Hamas leaders weren't just hiding underground, they were running their terror network from beneath a hospital. — Israel Defense Forces (@IDF) June 8, 2025 In a statement, the IDF said 'Several items belonging to Sinwar and Sabaneh were located, along with additional intelligence findings that were transferred for further investigation,' BBC reported. IDF took a small group of foreign journalists to Khan Younis in Gaza and showed them the tunnel on Sunday. The IDF also put out a video of the small entrance of the tunnel, which was accessible through the freshly dug soil in front of the hospital. IDF spokesperson Brig Gen Effie Defrin confirmed the development and stated that in one of the rooms they found Sinwar's body, which was located in the narrow underground corridor of the tunnel. 'This is another example of the cynical use by Hamas, using civilians as human shields, using civilian infrastructure, hospitals, again and again,' Defrin said.
Time of India
2 hours ago
- Time of India
HP agri varsity staff to CM Sukhvinder Singh Sukhu: Withdraw state govt's plea against HC stay on land transfer
Kullu: The teachers' association of Himachal Pradesh Agriculture University, Palampur, has urged chief minister Sukhvinder Singh Sukhu to withdraw a special leave petition (SLP) which the state govt recently filed in the Supreme Court. The petition challenges a stay order by the Himachal Pradesh high court on the transfer of 112 hectares of university land to the tourism department. In a letter to the CM, the Himachal Pradesh Agricultural University Teachers' Association (HPAUTA), which has been opposing the land transfer for a proposed tourism village, said this state govt project would jeopardise agricultural education and research in a premium agricultural university. According to the association, govt should withdraw the SLP so that the university's academic, research, and extension work was not affected adversely. Prof Janardan Singh, the secretary of HPAUTA, told TOI that the university land was meant solely for academic and research purposes, not commercial. "The land transfer would not only halt major ongoing research projects, including those funded by the Indian Council of Agricultural Research (ICAR), but also hinder the university's future expansion as no land would be left for new colleges, departments, or student facilities. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Your Address of Pride – Signature Global SPR Signature Global Book Now Undo The proposed village would weaken the academic mission of the university," said Prof Singh. He said state govt's move to approach the SC also raised several questions about its intent. "Why is the govt in such a hurry to establish a tourism village on the university campus when several hectares of land under various departments of the Himachal Pradesh govt lie unused? The state govt is unnecessarily putting the future of a premium institute of learning at risk," added Prof Singh. Despite protests and stiff opposition from teachers and students, the state govt last year transferred 112 hectares of university land to the tourism department for developing a tourism village. Challenging the state govt's land transfer, HPAUTA approached the Himachal Pradesh high court, which put a stay on the land transfer in August last year. Challenging the stay, state govt filed an SLP in the SC in March this year. Established in 1978, Himachal Pradesh Agriculture University, Palampur, in Kangra district was renamed Chaudhary Sarvan Himachal Pradesh Agriculture University in 2001. The university was awarded 14th rank among the Indian agriculture universities by ICAR in 2019. So far, the university has released 179 improved varieties of different crops for different regions of the state and is the first in the country to establish an advanced centre on nature farming. There are four constituent colleges of the university which impart education to over 2000 students from eight countries and 15 Indian states. If the transfer of the 112 hectares goes through, the university will be left with 277 hectares of land in its Palampur campus. According to teachers, the university will require more land for expansion in near future. "The university land has been squeezed whereas it needs to be expanded and new programmes are required to be started as per the new education policy. There is an urgent need to establish new colleges including the college of agricultural engineering, fisheries, agricultural business management, environmental sciences and more. Instead of providing more land to the university, the state govt is taking away whatever little it has got," said a university teacher, who didn't want to be named. The state govt announced in Nov 2023 to set up a tourism village in Kangra district to promote "local art and culture and to create employment opportunities for the youth".
